Advertisement

All News

    I’m Irked by the Cancer Stereotypes Portrayed on TV

    August 23rd 2022

    From bald heads paired with lush eyebrows to the typical emaciated patient, there are certain tropes of how cancer is portrayed on TV that bother me, as they do not represent the experiences of everyone with the disease.

    Here’s How Cancer Survivors Cope With Fear of Recurrence

    August 23rd 2022

    CURE® surveyed its audience to see how they cope with fear of cancer recurrence. Here’s what they had to say.

    Ayvakit Improves Disease Burden, Quality of Life in Mastocytosis

    August 23rd 2022

    Treatment with Ayvakit was associated with promising outcomes in patients with mastocytosis, according to findings from the PIONEER trial.

    The Hard Truth About Young Women Facing Breast Cancer

    August 22nd 2022

    My doctor once told me that if you're old enough to fight for your country, then you're old enough to get breast cancer.

    First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

    August 22nd 2022

    Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

    A Letter to Those Newly Diagnosed With Cancer, Including My Younger Self

    August 22nd 2022

    As I reflect on four years of “warriorhood” since being diagnosed with cancer, I wrote a letter to my younger self and others who are just receiving diagnosis.

    Unraveling the Layers of Metastatic Breast Cancer

    August 22nd 2022

    The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

    Revlimid-Rituxan Combo May Offer Alternative to Chemotherapy for Lymphoma Subtype

    August 22nd 2022

    The combination treatment demonstrated survival and safety results similar to those of chemotherapy for patients with advanced, untreated follicular lymphoma.

    What Makes an Oncology Nurse Great

    August 21st 2022

    Janet M. McFadden, RN-BC, B.S., MT(ASCP) understands the medical issues her patients are facing. She is calm and compassionate with her patients.

    The Nurse Every Patient Needs to Get Through the Journey

    August 20th 2022

    Often patients read online profiles of medical providers to decide where to receive care. In reality, having a nurse like Christine is so much more important.

    FDA Lifts Partial Hold on Trial Investigating Emavusertib in Lymphoma

    August 19th 2022

    The FDA has allowed the manufacturer of emavusertib to continue a phase 1/2 study investigating effects of the treatment in patients with lymphoma.

    I’m In a Great Place With My Cancer Despite Feeling 25 Years Older Than I Am

    August 19th 2022

    I am still here fighting, fighting hard and I will continue to do so to make sure I have more graduations, more weddings, and more everything that I can squeeze into my precious time left here on earth.

    ESPN Analyst Dick Vitale Announces He is Cancer-Free, WHO Deems Firefighting a Cancer-Causing Profession and More

    August 19th 2022

    From ESPN analyst Dick Vitale announcing he is cancer-free months following a lymphoma diagnosis to a Speedo-clad race in South Africa to raise awareness for cancer, here’s what’s happening in the oncology space this week.

    A Total Package of Compassion and Commitment for Patients With Cancer

    August 19th 2022

    Not only does she have incredible clinical intuition and ability, but she has a deep compassion and commitment to her patients that is truly unparalleled.

    First Patient Receives Treatment With Investigational CAR-T Cell Therapy-Opdivo Combo for Hodgkin Lymphoma

    August 18th 2022

    A representative of the company developing the investigational CAR-T cell therapy noted that they hypothesize that the combination “has the potential to further enhance efficacy and provide patients with a chemotherapy-sparing, second-line treatment option.”

    New Study to Explore Safety and Efficacy of a Single-Infusion CAR-T Cell Treatment in Patients With Colon Cancer

    August 18th 2022

    Investigators plan to analyze if treatment with an experimental, CAR-T cell therapy is safe and effective in a small group of patients with relapsed or refractory metastatic colorectal cancer.

    I Don’t Regret My Choice to Forgo Chemotherapy

    August 18th 2022

    My choice to not undergo chemotherapy for breast cancer was not an easy one, but looking back, I don’t regret it.

    FDA OKs New Drug Application for Momelotinib to Treat Myelofibrosis

    August 18th 2022

    The FDA has set a date to decide whether or not to approve momelotinib for myelofibrosis, a rare type of blood cancer.

    A One-in-a-Million Oncology Nurse Practitioner

    August 18th 2022

    Like all good oncology nurse practitioners, she has a deep knowledge of cancer medicine, and I would trust her to care for anyone in my family.

    FDA Grants Priority Review to Lynparza-Based Combination for Metastatic Prostate Cancer

    August 17th 2022

    If approved, the Lynparza-based regimen would become the first combination of a PARP inhibitor and a hormonal agent for metastatic castration-resistant prostate cancer.

    Patient With Metastatic Breast Cancer Recalls Witness of Data Leading to Enhertu Approval in HER2-Low Disease

    August 17th 2022

    A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

    I’m Still Alive With Cancer, But I Want More

    August 17th 2022

    Cancer and COVID-19 took away my yearly “benchmarks” of time, when I fly out to see friends and family.

    Was My Cancer Diagnosis Really a Fluke Like My Oncologist Said?

    August 17th 2022

    Prior to my breast cancer diagnosis, my only goal in life was for my son to turn 16 so he could drive me to and from the local bars. Now I can’t help but think that my cancer was meant for me to change my life.

    Patient and Oncology Nurse Empowerment

    August 17th 2022

    Janet brings our values at Fox Chase Cancer Center to life.

    A Look at Mindset, Optimism in Life After Cancer

    August 16th 2022

    As I recover from the traumatic effects of cancer, I’m realizing that success has much to do with mindset and optimism.

    Trodelvy Elicits Significant Survival Improvement in A Group of Patients With Pre-Treated Metastatic Breast Cancer

    August 16th 2022

    The use of Trodelvy was associated with a significant improvement in survival when compared with physician’s choice of chemotherapy in patients with HR-positive, HER2-negative metastatic breast cancer, according to recently announced study findings.

    I Use a Simple Button to Combat Anti-Maskers, Since Cancer Made Me Immunocompromised

    August 16th 2022

    I was shocked at a recent doctor appointment when practically nobody in the office was wearing a mask.

    Study to Investigate if Exercise Improves Outcomes, Decreases Chemo Side Effects in Colon Cancer

    August 16th 2022

    A new study will analyze the effect of exercise on chemotherapy tolerability and outcomes in patients with colon cancer.

    Investigational Drug-Chemoradiotherapy Combo Improves Treatment Responses in Patients With Advanced Rectal Cancer

    August 15th 2022

    The researchers hypothesize that treatment with the investigational drug combined with chemoradiotherapy may reduce the need for invasive surgery to remove the rectum and surrounding tissue in this patient population.

    Study to Investigate If Novel Drug Overcomes PARP Inhibitor Resistance in Breast Cancer

    August 15th 2022

    A phase 2 trial will analyze the novel drug ART4215 with Talzenna, a PARP inhibitor, for patients with BRCA-deficient breast cancer.

    NEXT PAGE
    PREVIOUS PAGE
    Advertisement
    Advertisement